A CD4/T4 receptor peptide ligand labeled with technetium-99m:: Synthesis and biological activity

被引:9
作者
Boschi, A
Uccelli, L
Bolzati, C
Marastoni, M
Tomatis, R
Spisani, S
Traniello, S
Piffanelli, A
机构
[1] Univ Ferrara, Dept Clin & Expt Med, Nucl Med Lab, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[3] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy
关键词
Tc-99m radiopharmaceuticals; peptides; imaging of receptors; cyclam;
D O I
10.1016/S0969-8051(00)00165-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The octapeptide D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 ([D-Ala(1)]TNH2), an analog of peptide T (H-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-OH) associated with CD4/T-4 receptors involved in human immunodeficiency virus infection, was combined with the chelating polyazamacrocycle 1,4,8,11-tetraazacyclotetradecane (cyclam) to afford the bifunctional ligand cyc-[D-Ala(1)]TNH2, This was then reacted with [(TcO4)-Tc-99m]- and Sn2+ to yield the monocationic complex [Tc-99m(O)(2)(c) (cyc-[D-Ala(1)]TNH2)](+). Biological activity of both the cyclam-peptide conjugate and the resulting Tc-99m complex were evaluated by measuring their chemotactic indexes. Results showed that N-cyclam acylation and subsequent labeling with Tc-99m of [D-Ala(1)]TNH2 were tolerated, and both cyc-[D-Ala(1)]TNH2 and [Tc-99m(O)(2)(cyc-[D-Ala(1)]TNH2)](+) retained the high chemotactic capacity of the original octapeptide. Biodistribution of the Tc-99m complex was carried out in rats, Fast blood clearance and no accumulation in organs of interest were observed. NUCL MED BIOL 27;8:791-795, 2000. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:791 / 795
页数:5
相关论文
共 10 条
[1]  
FRANZ J, 1987, NUCL MED, V16, P569
[2]  
Marastoni M, 1998, ARZNEIMITTEL-FORSCH, V48, P1039
[3]  
PASQUALINI R, 1992, APPL RADIAT ISOTOPES, V43, P1329
[4]   CD4 RECEPTOR-BINDING PEPTIDES THAT BLOCK HIV INFECTIVITY CAUSE HUMAN MONOCYTE CHEMOTAXIS - RELATIONSHIP TO VASOACTIVE INTESTINAL POLYPEPTIDE [J].
RUFF, MR ;
MARTIN, BM ;
GINNS, EI ;
FARRAR, WL ;
PERT, CB .
FEBS LETTERS, 1987, 211 (01) :17-22
[5]  
SIMON J, 1981, RADIOCHEM RADIOA LET, V47, P111
[6]   TC-99M-LABELED HOE-140 - A POTENTIAL BRADYKININ B-2 RECEPTOR IMAGING AGENT [J].
STAHL, W ;
BREIPOHL, G ;
KUHLMANN, L ;
STEINSTRASSER, A ;
GERHARDS, HJ ;
SCHOLKENS, BA .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (15) :2799-2801
[7]   A BIOACTIVE FULLERENE PEPTIDE [J].
TONIOLO, C ;
BIANCO, A ;
MAGGINI, M ;
SCORRANO, G ;
PRATO, M ;
MARASTONI, M ;
TOMATIS, R ;
SPISANI, S ;
PALU, G ;
BLAIR, ED .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (26) :4558-4562
[8]  
VERTUANI G, 1987, INT J PEPT PROT RES, V29, P525
[9]   LABELING OF AMINE LIGANDS WITH TC-99M IN AQUEOUS-SOLUTIONS BY LIGAND-EXCHANGE [J].
VOLKERT, WA ;
TROUTNER, DE ;
HOLMES, RA .
INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1982, 33 (10) :891-896
[10]   LEUKOCYTE LOCOMOTION AND CHEMOTAXIS - NEW METHODS FOR EVALUATION AND DEMONSTRATION OF A CELL-DERIVED CHEMOTACTIC FACTOR [J].
ZIGMOND, SH ;
HIRSCH, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1973, 137 (02) :387-410